Patent details

EP2115159 Title: ASSAYS FOR MODULATORS OF PARKIN ACTIVITY USING NOVEL SUBSTRATES

Basic Information

Publication number:
EP2115159
PCT Application Number:
PCT/US/2008/052700
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP087287538
PCT Publication Number:
WO/2008/095126
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ASSAYS FOR MODULATORS OF PARKIN ACTIVITY USING NOVEL SUBSTRATES
French Title of Invention:
DOSAGES DE MODULATEURS DE L'ACTIVITE DE LA PARKINE UTILISANT DE NOUVEAUX SUBSTRATS
German Title of Invention:
ASSAYS FÜR MODULATOREN DER PARKIN-AKTIVITÄT MITHILFE NEUARTIGER SUBSTRATE
SPC Number:

Dates

Filing date:
31/01/2008
Grant date:
21/12/2011
EP Publication Date:
21/12/2011
PCT Publication Date:
07/08/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/11/2009
EP B1 Publication Date:
21/12/2011
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
31/01/2012
Expiration date:
31/01/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
31/01/2008
 
 

Name:
Elan Pharma International Limited
Address:
800 Gateway Boulevard, South San Francisco, CA 94080, United States (US)

Inventor

1

Name:
GOLDBERG Alfred
Address:
United States (US)

2

Name:
JOHNSTON Jennifer, A.
Address:
United States (US)

Priority

Priority Number:
898947 P
Priority Date:
31/01/2007
Priority Country:
United States (US)

Classification

Main IPC Class:
C12Q 1/25;
Filing date Document type Number of pages